Quantcast

Granite State Times

Thursday, November 21, 2024

New Hampshire: Biologics companies were the least FDA inspected companies in New Hampshire in March

Webp ishuwpt6uyanzpnvvfpnzrwi0yoq

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

In March, one Biologics company received an FDA inspection in New Hampshire, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in New Hampshire, equalling 33.3% of all inspections in March.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in New Hampshire During March
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Foodborne Biological Hazards2----
Human Cellular, Tissue, and Gene Therapies--1--
Vaccines and Allergenic Products1----

MORE NEWS